Cellular Engineering Technologies Inc

Cellular Engineering Technologies, Inc. (CET) provides optimized reagents and human cell lines that address the technical and clinical challenges of developing next-generation cell therapies and regenerative medicines. We offer native, human recombinant growth factors and cytokines that are designed to generate maximum cellular response and bioavailability. Our portfolio of human somatic stem cells and induced pluripotent stem cells, programmed using our patented virus and oncogene-free methods, produce the safest and most scalable starting cell line for your research and manufacturing needs. We also leverage our human protein expression models to create custom protein and peptide sequences. Contact one of our...

Stem cell research,tissue engineering,t-cell engineering,bioproduction,growth factors & cytokines,cell culture supplements,human somatic stem cells,induced pluripotent stem cells (ipscs),allogeneic cell therapies,and neurodegenerative disease

Cellular engineering technologies inc operates in the Biotechnology research industry.

Cellular engineering technologies inc's revenue is 11m - 100m

Cellular engineering technologies inc has 11 - 50 employees.